These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35020192)

  • 1. Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.
    Kelly CR; Saw JL; Thapa P; Mandrekar J; Naddaf E
    Muscle Nerve; 2022 Apr; 65(4):415-421. PubMed ID: 35020192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
    Xiao T; Yang H; Gan S; Wu L
    Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
    Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
    Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.
    Chen TH; Lai YH; Lee PL; Hsu JH; Goto K; Hayashi YK; Nishino I; Lin CW; Shih HH; Huang CC; Liang WC; Wang WF; Jong YJ
    Neuromuscul Disord; 2013 Apr; 23(4):298-305. PubMed ID: 23434070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.
    Lutz KL; Holte L; Kliethermes SA; Stephan C; Mathews KD
    Neurology; 2013 Oct; 81(16):1374-7. PubMed ID: 24042093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal and genitourinary symptoms in facioscapulohumeral muscular dystrophy: Prevalence and impact.
    Cole MR; Cooper CS; Hanna EM; Zimmerman MB; Kinoshita J; Mathews KD
    Muscle Nerve; 2024 Mar; 69(3):325-333. PubMed ID: 38158588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
    Goselink RJM; Voermans NC; Okkersen K; Brouwer OF; Padberg GW; Nikolic A; Tupler R; Dorobek M; Mah JK; van Engelen BGM; Schreuder THA; Erasmus CE
    Neuromuscul Disord; 2017 Dec; 27(12):1077-1083. PubMed ID: 29102079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal and other unusual presentations of facioscapulohumeral muscular dystrophy.
    Hassan A; Jones LK; Milone M; Kumar N
    Muscle Nerve; 2012 Sep; 46(3):421-5. PubMed ID: 22907234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.
    Goselink RJM; Schreuder THA; van Alfen N; de Groot IJM; Jansen M; Lemmers RJLF; van der Vliet PJ; van der Stoep N; Theelen T; Voermans NC; van der Maarel SM; van Engelen BGM; Erasmus CE
    Ann Neurol; 2018 Nov; 84(5):627-637. PubMed ID: 30179273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
    Tawil R; Kissel JT; Heatwole C; Pandya S; Gronseth G; Benatar M; ;
    Neurology; 2015 Jul; 85(4):357-64. PubMed ID: 26215877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory pattern in a FSHD pediatric population.
    Trucco F; Pedemonte M; Fiorillo C; Tacchetti P; Brisca G; Bruno C; Minetti C
    Respir Med; 2016 Oct; 119():78-80. PubMed ID: 27692152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facioscapulohumeral muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus.
    Stübgen JP
    Dysphagia; 2008 Dec; 23(4):341-7. PubMed ID: 18259705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.